1. ggordon100
2. rdjr2
3. robflutie
4. 007Bondsman
5. prncsstss0
1.rdjr2 07/05/2018
Celgene settled its litigations with Accord Healthcare relating to patents for REVLIMID
2.robflutie 10/23/2017
Here is what is expected {Link}
3.ggordon100 01/22/2018
Should add a lot
4.rdjr2 09/20/2018
Biotech Celgene Seen Rebounding 10% on Higher Sales
5.ggordon100 07/10/2018
Phase III IMpassion130 study met co-primary endpoint
6.robflutie 06/01/2018
Announces results from the OPTIMISMM study at ASCO
7.rdjr2 10/23/2017
They have a lot in the pipeline, so Friday was a blip
8.rdjr2 03/21/2018
JPMorgan resumes coverage as an overweight, $110PT
9.007Bondsman 02/18/2018
OTEZLA® (Apremilast) Phase II Data Showed Clinically Meaningful Improvements in Patients with Active Ulcerative Colitis
10.rdjr2 01/23/2018
Surprised at the Neutral Rating Reiterate
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW